Position in CERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$230,327
-$25,021 QoQ
Shares Held
126,554
+2.1% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 0%
Shared 48%
None 52%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $562,208,190 across 46 Medical Devices names. CERS ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,587,219 | $162,959,773 | |
| 2 | SYK |
Stryker Corp
|
314,456 | $103,327,096 | |
| 3 | BSX |
Boston Scientific Corp
|
1,263,755 | $79,300,625 | |
| 4 | MDT |
Medtronic plc
|
756,044 | $65,511,212 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
330,573 | $23,530,185 | |
| 6 | STE |
STERIS plc
|
96,037 | $21,236,661 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
1,821,111 | $19,813,686 | |
| 8 | EW |
Edwards Lifesciences Corp
|
209,931 | $16,811,273 |
All Filings in CERS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $230,327 | 126,554 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $255,348 | 123,956 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $167,867 | 105,577 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $97,975 | 69,486 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $66,011 | 47,490 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $64,351 | 41,787 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $56,777 | 32,631 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $48,641 | 25,736 | Shares | Sole | 2024-05-14 | |
| 2021-06-30 | $147,750 | 25,000 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $150,250 | 25,000 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||